Inception Return
(9/25/2001)
|
6.02 %
|
|
YTD Return
|
7.51 %
|
|
NAVPS
(5/17/2024)
|
$38.67
|
|
Change
|
$0.05 / 0.13 %
|
|
|
Growth of $10,000
(As of April 30, 2024)
|
|
MER
|
2.25 %
|
|
Assets ($mil)
|
$22.26
|
|
Rank (1Yr)
|
100/171
|
|
Std Dev (3Yr)
|
12.64 %
|
|
Volatility Ranking (3Yr)
|
6/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
Back Fee Only
|
|
Max Front End
|
5.00 %
|
|
Max Back End
|
-
|
|
Sales Status
|
Open
|
|
|
Objective
The Fund aims to achieve long-term capital growth. It seeks a similar return to its underlying fund, which is also managed by Fidelity, by investing substantially all of its assets in units of that fund. The underlying fund aims to achieve long-term capital growth by investing primarily in equity securities of companies anywhere in the world that design, make or sell products or services related to health care and medicine.
|
Fund Manager
Fidelity Investments Canada ULC
Portfolio Manager
Alex Gold, Fidelity Investments Canada ULC
Amit Lodha, Fidelity Investments Canada ULC
Judith Finegold, Fidelity Investments Canada ULC
Sub-Advisor
Data not available
|
|
Asset Allocation
(As of March 31, 2024)
|
Sector Allocation
(As of March 31, 2024)
|
Geographic Allocation
(As of March 31, 2024)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| UnitedHealth Group Inc | US Equity | Healthcare | United States | 0.00% |
| Novo Nordisk A/S Cl B | International Equity | Healthcare | European Union | 0.00% |
| Eli Lilly and Co | US Equity | Healthcare | United States | 0.00% |
| Thermo Fisher Scientific Inc | US Equity | Healthcare | United States | 0.00% |
| Roche Holding AG - Partcptn | International Equity | Healthcare | Other European | 0.00% |
| Stryker Corp | US Equity | Healthcare | United States | 0.00% |
| Icon PLC | International Equity | Healthcare | European Union | 0.00% |
| Fidelity U.S. Money Market Investment Trust O | Cash and Equivalents | Cash and Cash Equivalent | United States | 0.00% |
| Boston Scientific Corp | US Equity | Healthcare | United States | 0.00% |
| HCA Healthcare Inc | US Equity | Healthcare | United States | 0.00% |
Performance Data
(As of April 30, 2024)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
-1.75
|
4.79
|
14.33
|
7.51
|
8.30
|
5.03
|
8.71
|
9.90
|
|
Benchmark
|
-1.82
|
4.10
|
16.91
|
4.68
|
8.73
|
7.59
|
8.86
|
7.22
|
|
Quartile Ranking
|
1
|
2
|
3
|
2
|
3
|
2
|
3
|
3
|
|
Calendar Return (%)
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
2014
|
|
Fund
|
2.95
|
-7.74
|
19.22
|
9.18
|
18.30
|
13.85
|
10.93
|
-15.20
|
26.57
|
30.52
|
|
Benchmark
|
11.75
|
-5.84
|
25.09
|
5.60
|
22.88
|
-8.89
|
9.10
|
21.08
|
-8.32
|
10.55
|
|
Quartile Ranking
|
3
|
2
|
2
|
4
|
3
|
1
|
3
|
4
|
2
|
1
|